Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
Another Blow To Aduhelm As Biogen Withdraws EU Filing
Adds To US Commercial Failure
Apr 25 2022
•
By
Andrew McConaghie
and
Neena Brizmohun
Biogen has withdrawn its filing with the EMA but has indicated it could resubmit if the evidence base changes. • Source: Alamy
More from Business
More from Scrip